DD283331A5 - Verfahren zur herstellung eines impfstoffes zum schutz von gefluegel vor escherichia coli-septikaemie - Google Patents

Verfahren zur herstellung eines impfstoffes zum schutz von gefluegel vor escherichia coli-septikaemie Download PDF

Info

Publication number
DD283331A5
DD283331A5 DD88321101A DD32110188A DD283331A5 DD 283331 A5 DD283331 A5 DD 283331A5 DD 88321101 A DD88321101 A DD 88321101A DD 32110188 A DD32110188 A DD 32110188A DD 283331 A5 DD283331 A5 DD 283331A5
Authority
DD
German Democratic Republic
Prior art keywords
fimbriae
vaccine
coli
production
immunogenic
Prior art date
Application number
DD88321101A
Other languages
German (de)
English (en)
Inventor
Johannes F Van Den Bosch
Original Assignee
��������@�K@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@�K@�Kk�� filed Critical ��������@�K@�Kk��
Publication of DD283331A5 publication Critical patent/DD283331A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DD88321101A 1987-10-26 1988-10-26 Verfahren zur herstellung eines impfstoffes zum schutz von gefluegel vor escherichia coli-septikaemie DD283331A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702536 1987-10-26

Publications (1)

Publication Number Publication Date
DD283331A5 true DD283331A5 (de) 1990-10-10

Family

ID=19850813

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88321101A DD283331A5 (de) 1987-10-26 1988-10-26 Verfahren zur herstellung eines impfstoffes zum schutz von gefluegel vor escherichia coli-septikaemie

Country Status (19)

Country Link
US (2) US5208024A (es)
EP (1) EP0314224B1 (es)
JP (1) JP2718523B2 (es)
KR (1) KR970005333B1 (es)
CN (1) CN1038559C (es)
AR (1) AR241634A1 (es)
AU (1) AU610940B2 (es)
CA (1) CA1331445C (es)
DD (1) DD283331A5 (es)
DE (1) DE3871489D1 (es)
DK (1) DK175528B1 (es)
ES (1) ES2042718T3 (es)
GR (1) GR3005517T3 (es)
HU (1) HU203673B (es)
IE (1) IE60324B1 (es)
NZ (1) NZ226677A (es)
PT (1) PT88850B (es)
YU (1) YU47473B (es)
ZA (1) ZA887694B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830709A (en) * 1989-10-27 1998-11-03 Benson; Roger E. Detection method for homologous portions of a class of substances
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
AU5715194A (en) * 1992-12-04 1994-07-04 N.V. Innogenetics S.A. New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
US5914114A (en) * 1995-06-02 1999-06-22 The United States Of America As Represented By The Secretary Of The Army Method of raising antibodies against E. coli of the family CS4-CFA/I
US6399074B1 (en) 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
DE10203652B4 (de) * 2002-01-30 2006-10-19 Westfalia Separator Ag Vollmantel-Schneckenzentrifuge mit einem Wehr
CN101948538A (zh) * 2010-10-19 2011-01-19 郑州后羿制药有限公司 一种抗大肠杆菌的鸡卵黄抗体精制方法
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
JPS58131920A (ja) * 1982-01-29 1983-08-06 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
ES8705033A1 (es) * 1984-12-04 1987-04-16 Biotech Australia Pty Ltd Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
DE69016129T2 (de) * 1989-08-18 1995-05-24 Akzo Nobel Nv Vakzin gegen Escherichia coli.

Also Published As

Publication number Publication date
IE60324B1 (en) 1994-06-29
KR890006253A (ko) 1989-06-12
JP2718523B2 (ja) 1998-02-25
IE883130L (en) 1989-04-26
DK593488A (da) 1989-04-27
PT88850B (pt) 1993-01-29
CN1033008A (zh) 1989-05-24
HUT48122A (en) 1989-05-29
US5208024A (en) 1993-05-04
JPH01149734A (ja) 1989-06-12
CA1331445C (en) 1994-08-16
US5593679A (en) 1997-01-14
AU610940B2 (en) 1991-05-30
HU203673B (en) 1991-09-30
NZ226677A (en) 1990-09-26
DK175528B1 (da) 2004-11-22
GR3005517T3 (es) 1993-06-07
KR970005333B1 (ko) 1997-04-15
YU47473B (sh) 1995-10-03
EP0314224B1 (en) 1992-05-27
DK593488D0 (da) 1988-10-25
CN1038559C (zh) 1998-06-03
DE3871489D1 (de) 1992-07-02
AU2432988A (en) 1989-04-27
ES2042718T3 (es) 1993-12-16
YU193688A (en) 1990-06-30
EP0314224A1 (en) 1989-05-03
AR241634A1 (es) 1992-10-30
ZA887694B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
DE3504221C2 (de) Mittel zur passiven Immunisierung von Säugern
DE69829400T2 (de) Passive immunisierung gegen durch clostridium difficile verursachte krankheit
EP0643974B1 (de) Impfstoff gegen die Lyme-Krankheit
DE69535374T2 (de) Aktive immunisierung gegen ein siderophores rezeptorprotein
DE69635783T2 (de) Antigen omp26 aus haemophilus influenzae
DE69110082T2 (de) Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
DE69016129T2 (de) Vakzin gegen Escherichia coli.
DE69532588T2 (de) Verfahren zur verbesserung der immunogenität einer immunogenen zusammensetzung oder eines haptens und verwendung zur herstellung von impfstoffen
DE69432658T2 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE60011560T2 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
DE69034107T2 (de) Impfstoffe gegen Bakterien, die zur Blutvergiftung führen
DD283331A5 (de) Verfahren zur herstellung eines impfstoffes zum schutz von gefluegel vor escherichia coli-septikaemie
DE69110997T2 (de) Haemophilus Paragallinarum-Impfstoffe.
DE60038099T2 (de) Neisseria impfstoffzusammensetzungen und methoden
DE69836520T2 (de) Clostridium perfringens Impfstoff
DE60125528T2 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
DE69635952T2 (de) Camp faktor aus streptococcus uberis
EP1183374A1 (de) Rekombinantes fusionsprotein, dieses enthaltende (impf-)stoffzusammensetzung und verfahren zu dessen herstellung
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
DE10152307A1 (de) Neue bakterielle Geflügelkrankheit
DE69734761T2 (de) Aus hemophilus paragallinarum abstammendes polypeptid und verfahren zu dessen herstellung
DE60032293T2 (de) Lebende attenuierte bakterien zur verwendung als impfstoff
DE69333402T2 (de) Impfstoff beinhaltend bacterin und toxoid aus pasteurella haemolytica typ a-1
DE60033823T2 (de) Rekombinante mikroorganismen
DE3878982T2 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20081027